K Opatrný

951 total citations
58 papers, 726 citations indexed

About

K Opatrný is a scholar working on Nephrology, Hematology and Surgery. According to data from OpenAlex, K Opatrný has authored 58 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Nephrology, 16 papers in Hematology and 12 papers in Surgery. Recurrent topics in K Opatrný's work include Dialysis and Renal Disease Management (27 papers), Erythropoietin and Anemia Treatment (10 papers) and Central Venous Catheters and Hemodialysis (7 papers). K Opatrný is often cited by papers focused on Dialysis and Renal Disease Management (27 papers), Erythropoietin and Anemia Treatment (10 papers) and Central Venous Catheters and Hemodialysis (7 papers). K Opatrný collaborates with scholars based in Czechia, Germany and Slovakia. K Opatrný's co-authors include Tomáš Reischig, Miroslava Švecová, Vladislav Třeška, Pavel Jindra, F Sefrna, Jaromír Eiselt, Sylvie Opatrná, Jaroslav Ráček, Ladislav Trefil and Mirko Bouda and has published in prestigious journals such as Life Sciences, Transplantation and Nephrology Dialysis Transplantation.

In The Last Decade

K Opatrný

55 papers receiving 701 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Opatrný Czechia 17 294 260 136 135 90 58 726
O. Traindl Austria 14 147 0.5× 114 0.4× 133 1.0× 41 0.3× 20 0.2× 44 569
Harald Lange Germany 13 127 0.4× 124 0.5× 122 0.9× 44 0.3× 33 0.4× 22 511
Kathy Jabs United States 19 375 1.3× 75 0.3× 254 1.9× 94 0.7× 21 0.2× 42 1.1k
W H Hörl Austria 16 307 1.0× 45 0.2× 94 0.7× 360 2.7× 42 0.5× 32 787
A. Barrientos Spain 18 177 0.6× 133 0.5× 247 1.8× 38 0.3× 40 0.4× 73 863
R Oulès France 12 267 0.9× 104 0.4× 177 1.3× 44 0.3× 23 0.3× 32 531
Hermann Goehl Australia 11 317 1.1× 95 0.4× 217 1.6× 188 1.4× 38 0.4× 13 621
Miriam Zimmering Germany 16 267 0.9× 53 0.2× 151 1.1× 54 0.4× 112 1.2× 21 683
Volkmar Lufft Germany 13 159 0.5× 107 0.4× 148 1.1× 44 0.3× 29 0.3× 18 813
D Zevin Israel 13 156 0.5× 56 0.2× 135 1.0× 58 0.4× 59 0.7× 57 605

Countries citing papers authored by K Opatrný

Since Specialization
Citations

This map shows the geographic impact of K Opatrný's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Opatrný with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Opatrný more than expected).

Fields of papers citing papers by K Opatrný

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Opatrný. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Opatrný. The network helps show where K Opatrný may publish in the future.

Co-authorship network of co-authors of K Opatrný

This figure shows the co-authorship network connecting the top 25 collaborators of K Opatrný. A scholar is included among the top collaborators of K Opatrný based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Opatrný. K Opatrný is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Opatrný, K, et al.. (2007). The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols a comparison of thrombogenicity parameters. Nephrology Dialysis Transplantation. 22(10). 2978–2984. 20 indexed citations
2.
Opatrný, K, et al.. (2006). Effect of Regional Citrate Anticoagulation on Thrombogenicity and Biocompatibility During CVVHDF. Renal Failure. 28(2). 107–118. 6 indexed citations
3.
Opatrný, K, et al.. (2006). Does an alteration of dialyzer design and geometry affect biocompatibility parameters?. Hemodialysis International. 10(2). 201–208. 15 indexed citations
4.
Eiselt, Jaromír, et al.. (2006). The Effect of Intravenous Iron on Oxidative Stress in Hemodialysis Patients at Various Levels of Vitamin C. Blood Purification. 24(5-6). 531–537. 16 indexed citations
5.
Reischig, Tomáš, Pavel Jindra, J Mareš, et al.. (2005). Valacyclovir for Cytomegalovirus Prophylaxis Reduces the Risk of Acute Renal Allograft Rejection. Transplantation. 79(3). 317–324. 54 indexed citations
6.
Opatrná, Sylvie, K Opatrný, Jaroslav Ráček, & F Sefrna. (2003). Effect of icodextrin-based dialysis solution on peritoneal leptin clearance.. PubMed. 23(1). 89–91. 7 indexed citations
7.
Opatrný, K. (2003). Clinical importance of biocompatibility and its effect on haemodialysis treatment. Nephrology Dialysis Transplantation. 18(90005). 41v–44. 32 indexed citations
8.
Opatrný, K, Tomáš Reischig, Jörg Vienken, et al.. (2002). Does Treatment Modality Have an Impact on Anemia in Patients with Chronic Renal Failure? Effect of Low‐ and High‐Flux Biocompatible Dialysis. Artificial Organs. 26(2). 181–188. 12 indexed citations
9.
Opatrný, K, et al.. (2001). Do continuous renal replacement therapies require heparin rinse. The International Journal of Artificial Organs. 24(8). 535. 2 indexed citations
10.
Eiselt, Jaromír, Jaroslav Ráček, Ladislav Trefil, & K Opatrný. (2001). Effects of a Vitamin E‐Modified Dialysis Membrane and Vitamin C Infusion on Oxidative Stress in Hemodialysis Patients. Artificial Organs. 25(6). 430–436. 34 indexed citations
11.
Eiselt, Jaromír, et al.. (1999). [Free radicals and extracorporeal renal replacement therapy].. PubMed. 45(5). 319–24. 5 indexed citations
12.
Opatrný, K, et al.. (1999). The Anemia in Continuous Ambulatory Peritoneal Dialysis Patients Is Related to Kt/V Index. Artificial Organs. 23(1). 65–69. 3 indexed citations
14.
Opatrný, K, et al.. (1998). Tissue-Type Plasminogen Activator (tPA) and Its Inhibitor (PAI-1) in Patients Treated with Continuous Ambulatory Peritoneal Dialysis. American Journal of Nephrology. 18(3). 186–192. 13 indexed citations
15.
Opatrný, K. (1997). Hemostasis disorders in chronic renal failure.. PubMed. 62. S87–9. 16 indexed citations
16.
Opatrný, K, et al.. (1997). A Clinical Study to Assess the Effect of Heparin in Dialyzer Rinsing Solutions. The International Journal of Artificial Organs. 20(2). 112–118. 17 indexed citations
17.
Eiselt, Jaromír, et al.. (1996). [The effect of acetate-free biofiltration on anemia and use of erythropoietin].. PubMed. 135(16). 525–9. 1 indexed citations
18.
Opatrný, K, et al.. (1995). Hemocompatibility in Hemodialysis and Erythropoietin Therapy. Artificial Organs. 19(8). 814–820. 7 indexed citations
19.
Mujais, Salim, et al.. (1995). Synthetic modification of PAN membrane: biocompatibility and functional characterization. Nephrology Dialysis Transplantation. 10(supp3). 46–51. 20 indexed citations
20.
Opatrný, K, et al.. (1993). Clinical Study of High‐Flux Cuprammonium Rayon Hemodialysis Membranes. Artificial Organs. 17(12). 971–976. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026